PlainRecalls
FDA Devices Moderate Class II Ongoing

FlexLab (FLX) System. Potassium Test System. in vitro diagnostic

Reported: October 15, 2025 Initiated: September 3, 2025 #Z-0106-2026

Product Description

FlexLab (FLX) System. Potassium Test System. in vitro diagnostic

Reason for Recall

The FlexLab System Sample Integrity Module (SIM) includes function that determines the hemolysis, icterus, and lipemia (HIL) in blood samples. This function has not been evaluated for safety and effectiveness by the FDA, so its use may cause an increase in erroneous results or a delay in patient results.

Details

Recalling Firm
Inpeco S.A.
Units Affected
8 units
Distribution
US distribution to CA & NY.
Location
Lugano

Frequently Asked Questions

What product was recalled?
FlexLab (FLX) System. Potassium Test System. in vitro diagnostic. Recalled by Inpeco S.A.. Units affected: 8 units.
Why was this product recalled?
The FlexLab System Sample Integrity Module (SIM) includes function that determines the hemolysis, icterus, and lipemia (HIL) in blood samples. This function has not been evaluated for safety and effectiveness by the FDA, so its use may cause an increase in erroneous results or a delay in patient results.
Which agency issued this recall?
This recall was issued by the FDA Devices on October 15, 2025. Severity: Moderate. Recall number: Z-0106-2026.